Chinese Journal of Mycology 2021, Vol. 16 Issue (2): 131-136.
Previous Articles Next Articles
Received:2020-01-14
Published:2021-04-25
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: http://cjmycology.smmu.edu.cn:81/Jweb_zgzj/EN/
http://cjmycology.smmu.edu.cn:81/Jweb_zgzj/EN/Y2021/V16/I2/131
| [1] Park BJ, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS[J]. AIDS, 2009, 23(4):525-530. [2] Jongwutiwes U, Kiertiburanakul S, Sungkanuparph S. Impact of antiretroviral therapy on the relapse of cryptococcosis and survival of HIV-infected patients with cryptococcal infection[J]. Curr HIV Res, 2007, 5(3):355-360. [3] Manosuthi W, Chottanapund S, Sungkanuparph S. Mortality rate of early versus deferred initiation of antiretroviral therapy in HIV-1-infected patients with cryptococcal meningitis[J]. J Acquir Immune Defic Syndr, 2008, 48(4):508-509. [4] UNAIDS. UNAIDS DATA 2020.[EB/OL]. (2020-7-6).https://www.unaids.org/en/resources/documents/2020/unaids-data. [5] Rajasingham R, Smith RM, Park BJ, et al. Global burden of disease of HIV-associated cryptococcal meningitis:an updated analysis[J]. Lancet Infect Dis, 2017, 17(8):873-881. [6] Pyrgos V. Epidemiology of cryptococcal meningitis in the US:1997-2009[J]. PloS One, 2013, 8(2):e56269. [7] Bicanic T, Brouwer AE, Meintjes G, et al. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures[J]. AIDS, 2009, 23(6):701-706. [8] Senadim S, Alpaydin Baslo S, Tekin Güveli B, et al. A rare cause of cerebral venous thrombosis:cryptococcal meningoencephalitis[J]. Neurol Sci, 2016, 37(7):1145-1148. [9] Lan SH, Chang WN, Lu CH, et al. Cerebral infarction in chronic meningitis:a comparison of tuberculous meningitis and cryptococcal meningitis[J]. QJM, 2001, 94(5):247-253. [10] Vidal JE, Boulware DR. Lateral flow assay for cryptococcal antigen:an important advance to improve the continuum of HIV care and reduce cryptococcal meningitis-related mortality[J]. Rev Inst Med Trop Sao Paulo, 2015, 57(19):38-45. [11] Longley N, Jarvis JN, Meintjes G, et al. Cryptococcal antigen screening in patients initiating ART in South Africa:a prospective cohort study[J]. Clin Infect Dis, 2016, 62(5):581-587. [12] Jarvis, Joseph N, Lawn, et al.Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa[J]. Clin Infect Dis, 2009, 48(7):856-862. [13] Jarvis JN,Harrison TS,Lawn D, et al. Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa[J]. PloS One, 2013, 8(7):1-10. [14] Jarvis JN,Bicanic T,Loyse A, et al. Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis:implications for improving outcomes[J]. Clin Infect Dis, 2014, 58(5):736-745. [15] Bicanic T, Muzoora C, Brouwer AE, et al. Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis:analysis of a combined cohort of 262 patients[J]. Clin Infect Dis, 2009, 49:702-709. [16] Adeyemi B, Ross A. Profile and mortality outcome of patients admitted with cryptococcal meningitis to an urban district hospital in KwaZulu-Natal,South Africa[J]. J Int AIDS Soc, 2014, 17(3):19623. [17] Bicanic T, Wood R, Meintjes G, et al. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients:a randomized trial[J]. Clin Infect Dis, 2008, 47(1):123-130. [18] Jarvis JN, Meintjes G, Harrison TS, et al. Outcomes of cryptococcal meningitis inantiretroviral naive and experienced patients in South Africa[J]. J Infect, 2010, 60(6):496-498. [19] Kambugu A, Meya DB, Rhein J, et al. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy[J]. Clin Infect Dis, 2008, 46(11):1694-1701. [20] Grant PM, Komarow L, Andersen J, et al. Riskfactor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection[J]. PLoS ONE,2010,5(7):e11416. [21] Vander H, Saag MS, Cloud GA, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome[J]. N Engl J Med, 1997, 337(1):15-21. [22] Hamill RJ, Sobel JD, El-Sadr W, et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis:a randomized, double-blind clinical trial of efficacy and safety[J]. Clin Infect Dis, 2010, 51(2):225-532. [23] 鲁雁秋, 黄晓婕, 吴玉珊, 等. 203例艾滋病合并新型隐球菌性脑膜炎患者预后影响因素研究[J]. 中华神经医学杂志, 2018, 17(4):397-401. [24] 李太生, 王福生, 高福. 中国艾滋病诊疗指南(2018版)[J]. 中华内科杂志, 2018, 57(12):7-8. [25] Bozzette SA, Larsen RA, Chiu J, et al. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome[J]. N Engl J Med, 1991, 324(9):580-584. [26] Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis[J]. N Engl J Med, 1992, 326(2):83-89. [27] Saag MS, Cloud GA, Graybill JR, et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis[J]. Clin Infect Dis, 1999, 28(2):291-296. [28] Rolfes MA, Hullsiek KH, Rhein J, et al. The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis[J]. Clin Infect Dis,2014,59(11):1607-1614. [29] Bicanic T, Brouwer AE, Meintjes G, et al. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures[J]. AIDS, 2009, 23(6):701-706. [30] Graybill JR, Sobel J, Saag M, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis[J]. Clin Infect Dis, 2000, 30(1):47-54. [31] Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease:2010 update by the infectious diseases society of America[J]. Clin Infect Dis, 2010, 50(3):291-322. [32] Beardsley J, Wolbers M, Kibengo FM, et al. Adjunctive dexamethasone in HIV-associated cryptococcal meningitis[J]. N Engl J Med, 2016, 374(6):542-554. [33] Meintjes G, Scriven J, Marais S. Management of immune reconstitution inflammatory syndrome[J]. Curr HIV/AIDS Rep, 2012, 9(3):138-150. [34] Bonham S, Meya DB, Bohjanen PR. Boulware DR (2008) Biomarkers of HIV immune reconstitution inflammatory syndrome[J]. Biomark Med, 2008, 2(4):349-361. [35] Manabe YC, Campbell JD, Sydnor E. Immune reconstitution inflammatory syndrome:risk factors and treatment implications[J]. J Acquir Immune Defic Syndr, 2007, 46(4):456-462. [36] Bicanic T, Meintjes G, Rebe K, et al. Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis:a prospective study[J]. J Acquir Immune Defic Syndr, 2009, 51(4):130-134. [37] Boulware DR, Meya DB, Bergemann TL, et al. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after Cryptococcus meningitis:a prospective cohort study[J]. PLoS Med, 2010, 7(12):e1000384. [38] Colombo ERDC, Mora DJ, Silva-Vergara ML. Immune reconstitution inflammatorysyndrome (IRIS) associated with Cryptococcus neoformans infection in AIDS patients[J]. Mycoses, 2011, 54(4):178-182. [39] Sungkanuparph S, Giller SG, Chetchotisakd P, et al. Cryptococcal immune reconstitution syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis:a prospective multicenter study[J]. Clin Infect Dis, 2009, 49(6):931-934. [40] Boulware DR, Bonham SC, Meya DB, et al. Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome[J]. J Infect Dis, 2010, 202(6):962-970. [41] Chang CC, Dorasamy AA, Gosnell BI, et al. Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome[J]. AIDS, 2013, 27(13):2089-2099. [42] Haddow LJ, Easterbrook PJ, Mosam A, et al. Defining immune reconstitution inflammatory syndrome:evaluation of expert opinion versus 2 case definitions in a South African cohort[J]. Clin Infect Dis, 2009, 49(1):1424-1432. [43] Jarvis J.CSF cytokine profiles in patients with HIV-associated cryptococcal meningitis:correlates with clinical outcome[C]//the 8th International Conference on Cryptococcus and Cryptococcosis, Charleston, May 4, 2011. [44] Narayanan S, Banerjee C, Holt PA.Cryptococcal immune reconstitution syndrome during steroid withdrawal with hydroxychloroquine[J]. Internat J Infect Dis,2011, 15(1):70-73. [45] Scourfield A, Waters L, Tittle V, et al. Azathioprine use as a novel treatment for cryptococcal immune reconstitution and inflammatory syndrome in HIV[C]//17th Annual Conference of the British HIV Association, Bournemouth, 2011. [46] Brunel AS, Reynes J, Tuaillon E, et al. Thalidomide for steroid-dependent immune reconstitution inflammatory syndromes during AIDS[J]. AIDS, 2012, 26(16):2110-2111. [47] Sitapati AM, Kao CL, Cachay ER, et al.Treatment of HIV-related inflammatory cerebral cryptococcoma with adalimumab[J]. Clin Infect Dis, 2010, 50(2):7-10. [48] Haddow LJ, Colebunders R, Meintjes G, et al. Cryptococcal immune reconstitution syndrome in HIV-1 infected individuals:proposed clinical case definitions[J]. Lancet Infect Dis, 2010, 10(11):791-802. [49] Baldassarre R, Mdodo R, Omonge E, et al. Mortality after clinical management of AIDS-associated cryptococcal meningitis[J]. East Afr Med J, 2014, 91(5):145-151. [50] David R, Boulware, David B, et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis[J]. N Engl J Med, 2014, 370(26):2487-2498. [51] Ingrid EW, Okwen MP, Marty R, et al. Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis[J].Cochrane Database Syst Rev, 2018, 7(7):CD009012. |
| [1] | HUANG Jin-bao, LAN Chang-qing, WEN Heng, LIN Qing-hua. Cryptococcal infection of the ribs mimicking malignant tumor: two cases report and literature review [J]. Chinese Journal of Mycology, 2020, 15(5): 278-282. |
| [2] | TAO Peng-fei, YANG Xin-ping, LI Zheng-lun, ZHOU Qi-wen, MIN Hai-yan, QIAN Qing-jin. Clinical features and treatment outcome of 30 cases of AIDS complicated with invasive cryptococcosis [J]. Chinese Journal of Mycology, 2020, 15(3): 150-153. |
| [3] | WANG Li-lin, LI Ai-xin, YANG Xue, Wang Wen, Wu Hao. Clinical analysis for 67 AIDS patients with cryptococcal meningitis [J]. Chinese Journal of Mycology, 2019, 14(6): 342-345. |
| [4] | HE Yuan-hong, TAN qing, YANG Tong-tong, HE Sheng-hua, WANG Yin, ZHOU Rui-feng, CAI Lin. Efficacy and safety of amphotericin B in 124 AIDS-associated cryptococcal meningitis patients [J]. Chinese Journal of Mycology, 2019, 14(6): 346-350. |
| [5] | LU Yan-qiu, WU Yu-shan, QIU Dan, CHEN Yao-kai. Retrospective analysis of 149 cases of cryptococcal meningitis with AIDS [J]. Chinese Journal of Mycology, 2019, 14(4): 204-209. |
| [6] | . [J]. Chinese Journal of Mycology, 2019, 14(4): 232-234. |
| [7] | WANG Guang-yu, CHEN Min, HONG Nan, WANG Sheng-qi, LIAO Wan-qing, YANG Ying. Study on the diagnosis of cryptococcal meningoencephalitis by molecular biological techniques [J]. Chinese Journal of Mycology, 2019, 14(2): 95-98. |
| [8] | WANG Yan-ling, YANG Yu-heng, YU Nong, DENG Shu-wen. Clinical characteristics on 11 immunocompetent patients with pulmonary cryptococcosis and literature review [J]. Chinese Journal of Mycology, 2018, 13(3): 148-151,163. |
| [9] | XIE Jing, GE Ying, QIU Zhi-feng, ZHANG Kai-yu, LIU Zheng-yin, LI Tai-sheng. Immunophenotype of peripheral lymphocytes in HIV-negative patients with cryptococcal meningitis [J]. Chinese Journal of Mycology, 2017, 12(5): 262-267. |
| [10] | HUANG Huang, XIAN Ying, PAN Yue-jun, ZHANG Kou-xing. The proportions of Th1/Th2 and Relevant T lymphocytes in patients with cryptococcal meningitis and its clinical significance [J]. Chinese Journal of Mycology, 2017, 12(5): 268-273,267. |
| [11] | ZHU Bo-cheng, PAN-Bo, GE Guo-jun, GAO Quan, LOU Bo-yang, XU Zhi-jie, ZHU Xiao-feng. A patient with renal allograft failure and disseminated cryptococcosis:a case report [J]. Chinese Journal of Mycology, 2017, 12(5): 295-297. |
| [12] | ZHANG Li-yan, ZHANG Dong-lei, TAN Xiao-ming, XIE Hui-kang. Pulmonary cryptococcosis presenting as necrotizing granuloma:a clinicopathologic analysis of 28 cases [J]. Chinese Journal of Mycology, 2017, 12(4): 212-215. |
| [13] | CAI Ren-hui, WANG Ying. Analysis of prognosis and clinical characteristics in 22 patients with Cryptococcus neoformans meningitis [J]. Chinese Journal of Mycology, 2017, 12(4): 216-220. |
| [14] | LIU Jian-qing, SHI Hong, WU Guo-lan, CHEN Yu-yan. A case of disseminated cryptococcosis and literature review [J]. Chinese Journal of Mycology, 2017, 12(4): 225-227. |
| [15] | TAO Lu, ZHOU Wen-ming. A case of cryptococcal meningitis misdiagnosed as tuberculous meningitis [J]. Chinese Journal of Mycology, 2017, 12(3): 156-158,161. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
